We suggest that circHIPK3 may nucleate several copies of IGF2BP2 per circRNA molecule, likely via phase separation. More speculatively, only a small fraction of IGF2BP2 may be available for RNA binding or an enzymatic modification of IGF2BP2 may take place on the circRNA.